1 completed, 1 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Terminated 1 |
Follow Heavy Drinking: new trials by email Literature Review of Heavy Drinking trials Research Report on Heavy Drinking
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of Valproate on Ethanol Withdrawal Valproate, Lorazepam - Alcohol Dependence, Alcohol Withdrawal Syndrome | Phase 4 | Terminated | CAMC Health System | 3 | 2017-07-11 | 2026-08-18 |
| Alcohol Disorder hOsPital Treatment Trial Oral naltrexone (PO-NTX), Extended-release injectable naltrexone (XR-NTX) - Heavy Drinking, Alcohol Dependence | Phase 4 | Completed | Boston University | 248 | 2016-06-01 | 2021-06-29 |
Alcoholism (2) · Wounds and Injuries (1)
Alcohol-Related Disorders (2) · Chemically-Induced Disorders (2) · Mental Disorders (2) · Substance-Related Disorders (2)
Lorazepam (1) · Naltrexone (1) · Valproic Acid (1) · vivitrol (1)
Boston University (1) · CAMC Health System (1)
United States (2)
Audis Bethea, PharmD, BCPS (1) · Richard Saitz, MD, MPH (1)
R01AA021335 (1)